| CASE REPORT |
|
| Year : 2021 | Volume
: 9
| Issue : 2 | Page : 278-282 |
|
|
Dual Invasive fungal infection by aspergillus and mucor in COVID-19 patient: A rare case report with literature review
Deependra Kumar Rai1, Subhash Kumar2
1 Department of Pulmonary Medicine, AIIMS, Patna, Bihar, India
2 Department of Radio-diagnosis, AIIMS, Patna, Bihar, India
Correspondence Address:
Dr. Deependra Kumar Rai
Department of Pulmonary Medicine, AIIMS, Patna, Bihar
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/amhs.amhs_218_21
|
|
|
Patients with COVID-19, especially those with severe disease, in intensive care units, are particularly vulnerable to bacterial and fungal infections. The most common fungal infections reported include aspergillosis, candidiasis, and mucormycois. Mucormycosis, a potentially life-threatening fungal infection, has contributed to India's COVID-19-related deaths, especially during the second wave of pandemic. Several cases of COVID-19-associated pulmonary aspergillosis (CAPA) have been reported from many countries in Europe, Asia, Australia, and South America. Recently, several cases of rhino-orbito-cerebral mucormycosis in patients with COVID-19 (ROCM) have been reported from India. However, case of COVID-19-associated pulmonary mucormycosis (CAPM) is rarely described in the literature. It has been hypothesized to affect patients recovering from COVID-19 who are immunocompromised due to COVID-19 disease or due to the usage of steroids and/or concomitant diabetes. The authors hereby report a combination of CAPM and CAPA in the same patient and perform a systemic review of the published cases highlighting the differences between these two-life-threatening pulmonary fungal infections.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
